Is AbbVie a bad news buy?
Apr 03, 2022 · AbbVie's stock was trading at $84.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ABBV stock has increased by 97.2% and is now trading at $167.31. View which stocks have been most impacted by COVID-19.
Does AbbVie stock pay dividends?
See the company profile for AbbVie Inc. (ABBV) including business summary, industry/sector information, number of employees, business summary, …
Should you buy AbbVie for the dividend?
MarketWatch: Stock Market News - Financial News - MarketWatch
Why did AbbVie stock drop?
About AbbVie Inc. 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, Illinois, 60064-6400, United States +1 847 932-7900 AbbVie is a drug company with a strong exposure to immunology and oncology. The company's...
Is AbbVie a Buy Sell or Hold?
AbbVie has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 12 buy ratings, 4 hold ratings, and no sell ratings.
How much does AbbVie pay per share?
ABBV pays a dividend of $5.31 per share. ABBV's annual dividend yield is 3.17%. ABBVIE's dividend is higher than the US industry average of 3.11%, and it is lower than the US market average of 4.15%.
What is the target price for AbbVie?
Stock Price Forecast The 20 analysts offering 12-month price forecasts for Abbvie Inc have a median target of 165.50, with a high estimate of 192.00 and a low estimate of 115.00. The median estimate represents a +2.08% increase from the last price of 162.13.
Does AbbVie have a dividend?
(NYSE: ABBV) today declared a quarterly cash dividend of $1.41 per share. The cash dividend is payable May 16, 2022 to stockholders of record at the close of business on April 15, 2022. Since the company's inception in 2013, AbbVie has increased its dividend by more than 250 percent.Feb 17, 2022
How often is ABBV dividends?
4 dividends per yearDividend Summary There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 2.1.
How many years has AbbVie paid a dividend?
AbbVie (NYSE:ABBV) has increased its dividend for the past 50 consecutive years.
How high will Chevron stock go?
Chevron Corp (NYSE:CVX) The 25 analysts offering 12-month price forecasts for Chevron Corp have a median target of 180.00, with a high estimate of 213.00 and a low estimate of 130.00. The median estimate represents a +4.94% increase from the last price of 171.52.
Is ABBV a buy Zacks?
Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, AbbVie is rated Zacks Rank #3 (Hold). Even though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues.3 days ago
What company is ABBV?
AbbVie is a research-based biopharmaceutical company. It spun off of Abbott Laboratories in 2013. The company has had a successful start in its first five years in the industry.
Will AbbVie increase dividend in 2021?
Financial Release (NYSE: ABBV) today declared a quarterly cash dividend of $1.30 per share. The cash dividend is payable November 15, 2021 to stockholders of record at the close of business on October 15, 2021 . Since the company's inception in 2013, AbbVie has increased its dividend by 225 percent.
Will AbbVie raise its dividend in 2021?
The cash dividend is payable August 16, 2021 to stockholders of record at the close of business on July 15, 2021. Since the company's inception in 2013, AbbVie has increased its dividend by 225 percent.
Is AbbVie dividend sustainable?
AbbVie paid out 177% of profit in the past year, which we think is typically not sustainable unless there are mitigating characteristics such as unusually strong cash flow or a large cash balance. A useful secondary check can be to evaluate whether AbbVie generated enough free cash flow to afford its dividend.Apr 8, 2021
Is AbbVie a buy right now?
16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AbbVie in the last year. There are currently 4 hold rat...
How has AbbVie's stock price been impacted by COVID-19?
AbbVie's stock was trading at $84.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since th...
When is AbbVie's next earnings date?
AbbVie is scheduled to release its next quarterly earnings announcement on Friday, April 29th 2022. View our earnings forecast for AbbVie .
How were AbbVie's earnings last quarter?
AbbVie Inc. (NYSE:ABBV) issued its quarterly earnings data on Wednesday, February, 2nd. The company reported $3.31 earnings per share for the quart...
How often does AbbVie pay dividends? What is the dividend yield for AbbVie?
AbbVie announced a quarterly dividend on Thursday, February 17th. Stockholders of record on Friday, April 15th will be given a dividend of $1.41 pe...
Is AbbVie a good dividend stock?
AbbVie pays an annual dividend of $5.64 per share and currently has a dividend yield of 3.78%. AbbVie has been increasing its dividend for 50 conse...
What guidance has AbbVie issued on next quarter's earnings?
AbbVie updated its FY 2022 earnings guidance on Monday, February, 21st. The company provided earnings per share (EPS) guidance of $14.000-$14.200 f...
What price target have analysts set for ABBV?
16 brokers have issued 1-year target prices for AbbVie's shares. Their forecasts range from $122.00 to $180.00. On average, they expect AbbVie's st...
Who are AbbVie's key executives?
AbbVie's management team includes the following people: Richard A. Gonzalez , Chairman & Chief Executive Officer ( LinkedIn Profile ) Michael E....
Is AbbVie a buy right now?
What stocks does MarketBeat like better than AbbVie?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AbbVie in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AbbVie stock.#N#View analyst ratings for AbbVie or view top-rated stocks.
When is AbbVie's next earnings date?
Wall Street analysts have given AbbVie a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AbbVie wasn't one of them.
How were AbbVie's earnings last quarter?
AbbVie is scheduled to release its next quarterly earnings announcement on Friday, October 29th 2021.#N#View our earnings forecast for AbbVie.
How has AbbVie's stock price been impacted by COVID-19?
AbbVie Inc. (NYSE:ABBV) issued its quarterly earnings data on Thursday, July, 29th. The company reported $3.11 EPS for the quarter, beating analysts' consensus estimates of $3.09 by $0.02. The firm had revenue of $13.96 billion for the quarter, compared to analysts' expectations of $13.64 billion.
How often does AbbVie pay dividends? What is the dividend yield for AbbVie?
AbbVie's stock was trading at $84.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ABBV stock has increased by 26.7% and is now trading at $107.48.#N#View which stocks have been most impacted by COVID-19.
Is AbbVie a good dividend stock?
AbbVie announced a quarterly dividend on Friday, September 10th. Shareholders of record on Friday, October 15th will be given a dividend of $1.30 per share on Monday, November 15th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 4.84%. The ex-dividend date is Thursday, October 14th.#N#View AbbVie's dividend history.
Description
AbbVie pays an annual dividend of $5.20 per share and currently has a dividend yield of 4.87%. ABBV has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of AbbVie is 49.24%. This payout ratio is at a healthy, sustainable level, below 75%.
Corporate Governance
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide.
Recently Viewed Tickers
AbbVie Inc.’s ISS Governance QualityScore as of July 1, 2021 is 8. The pillar scores are Audit: 9; Board: 5; Shareholder Rights: 9; Compensation: 4.
AbbVie Inc
Visit a quote page and your recently viewed tickers will be displayed here.
What is AbbVie's dividend yield?
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products.
When is AbbVie's next dividend payment?
The current dividend yield for AbbVie (NYSE:ABBV) is 4.85%. Learn more
When was AbbVie's most recent dividend payment?
AbbVie's next $106.36 - $108.32 dividend payment of $1.30 per share will be made to shareholders on Monday, November 15, 2021.
When did AbbVie last increase or decrease its dividend?
AbbVie's most recent $106.36 - $108.32 dividend payment of $1.30 per share was made to shareholders on Monday, August 16, 2021.
Signals & Forecast
The most recent change in AbbVie's dividend was an increase of $0.12 on Friday, October 30, 2020.
Support, Risk & Stop-loss
There are few to no technical positive signals at the moment. The AbbVie Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is AbbVie Inc stock A Buy?
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
